ArticleDiabetes, obesity & metabolism2023

Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database.

Ameenathul Mazaya Fawzy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.